Trial of Imatinib (Gleevec®) in Selected Patients With Metastatic Melanoma
Clinical trial NCT00881049 · COMPLETED
Trial details
- NCT number
- NCT00881049
- Sponsor
- Peking University
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2008-12-01
- Primary completion
- 2011-01-01
- Enrollment
- 1
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.